Abstract: The work described in this paper represents an improvement over a previously published method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine by solid phase extraction on a molecularly imprinted polymer column coupled with HPLC and -MS/MS detection. The influence of ion suppression due to sample matrix effect was evaluated, and found to influence the response of NNAL. By changing the liquid chromatography conditions, the response for this method was enhanced approximately 25-fold through avoidance of ionization suppression that was found with a previously published method and sample throughput has been improved. The dynamic range of the assay extends from 20 to 2500ápg/mL with a mean r2á>á0.998. The lower limit of quantitation for the assay was 20ápg/mL despite the use of an inherently lower sensitivity instrument. The method was validated according to current FDA guidelines for bioanalytical method validations
Template and target information: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, NNAL
Author keywords: Tobacco specific nitrosamine, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, NNAL, molecularly imprinted polymer, Matrix effect, LC-MS, MS